报价延迟最少15分钟:2026/04/28 07:30 EDT
盘前时段
|
||||
|
299.79 
|
|
|
常规时段 (已结束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
299.79
|
|
|
| 价值评估 |
|
盈利(现时/预测)
10.76/17.53
|
|
企业价值
31.42B
|
| 资产负债 |
|
每股账面净值
26.09
|
| 现金流量 |
|
现金流量率
0.04
|
| 损益表 |
|
收益
3.17B
|
|
每股收益
30.51
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools. |
